285 related articles for article (PubMed ID: 27702885)
1. Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.
Li WM; Zhao YF; Zhu GF; Peng WH; Zhu MY; Yu XJ; Chen W; Xu DC; Xu YW
Clin Sci (Lond); 2017 Jan; 131(2):141-154. PubMed ID: 27702885
[TBL] [Abstract][Full Text] [Related]
2. DUSPs as critical regulators of cardiac hypertrophy.
Tilley DG; Sabri A
Clin Sci (Lond); 2017 Jan; 131(2):155-158. PubMed ID: 28011900
[TBL] [Abstract][Full Text] [Related]
3. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
4. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
[TBL] [Abstract][Full Text] [Related]
5. DUSP12 protects against hepatic ischemia-reperfusion injury dependent on ASK1-JNK/p38 pathway in vitro and in vivo.
Qiu T; Wang T; Zhou J; Chen Z; Zou J; Zhang L; Ma X
Clin Sci (Lond); 2020 Sep; 134(17):2279-2294. PubMed ID: 32803262
[TBL] [Abstract][Full Text] [Related]
6. Dual-specificity phosphatase 12 attenuates oxidative stress injury and apoptosis in diabetic cardiomyopathy via the ASK1-JNK/p38 signaling pathway.
Li H; Yang Q; Huang Z; Liang C; Zhang DH; Shi HT; Du JQ; Du BB; Zhang YZ
Free Radic Biol Med; 2022 Nov; 192():13-24. PubMed ID: 36108935
[TBL] [Abstract][Full Text] [Related]
7. Expression of DUSP12 Reduces Lung Vascular Endothelial Cell Damage in a Murine Model of Lipopolysaccharide-Induced Acute Lung Injury via the Apoptosis Signal-Regulating Kinase 1 (ASK1)-Jun N-Terminal Kinase Activation (JNK) Pathway.
Hui Z; Jie H; Fan GH
Med Sci Monit; 2021 Apr; 27():e930429. PubMed ID: 33811209
[TBL] [Abstract][Full Text] [Related]
8. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
Ma ZG; Yuan YP; Zhang X; Xu SC; Kong CY; Song P; Li N; Tang QZ
Cardiovasc Res; 2019 May; 115(6):1067-1077. PubMed ID: 30407523
[TBL] [Abstract][Full Text] [Related]
9. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
10. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways.
Huang Z; Wu LM; Zhang JL; Sabri A; Wang SJ; Qin GJ; Guo CQ; Wen HT; Du BB; Zhang DH; Kong LY; Tian XY; Yao R; Li YP; Liang C; Li PC; Wang Z; Guo JY; Li L; Dong JZ; Zhang YZ
Hepatology; 2019 Oct; 70(4):1099-1118. PubMed ID: 30820969
[TBL] [Abstract][Full Text] [Related]
11. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
12. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
13. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
14. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
15. Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy.
Tang K; Zhao Y; Li H; Zhu M; Li W; Liu W; Zhu G; Xu D; Peng W; Xu YW
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28432072
[TBL] [Abstract][Full Text] [Related]
16. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
20. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
